Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Adam Hloska"'
Autor:
Martin Wawruch, Dusan Zatko, Adam Hloska, Gejza Wimmer, Vasil Hricak, Jan Murin, Rashmi Shah, Tomas Tesar, Peter Kukumberg, Jan Luha
Publikováno v:
Pharmacoepidemiology and Drug Safety. 26:201-207
PURPOSE This study was aimed at evaluating the extent of non-persistence with statin therapy in elderly patients after an ischemic stroke and identifying patient-related characteristics that are risk factors for non-persistence. METHODS The evaluable
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::929ef4674cf2510f5304616c7721de54
https://doi.org/10.1002/pds.4148
https://doi.org/10.1002/pds.4148
Autor:
Gejza Wimmer, Peter Kukumberg, Zoltan Kallay, Jan Luha, Rashmi Shah, Tomas Tesar, Adam Hloska, Dusan Zatko, Lenka Kuzelova, Jan Murin, Martin Wawruch
Publikováno v:
Drugs & Aging. 33:365-373
This study investigated the extent of, and patient-related characteristics for, non-persistence with antiplatelet therapy during follow-up in elderly patients after their first ischaemic non-cardioembolic stroke. A database of the largest health insu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c6cd13eef5a7c9d0d91a24ff9e09bdb
https://doi.org/10.1007/s40266-016-0365-2
https://doi.org/10.1007/s40266-016-0365-2
Publikováno v:
International journal of technology assessment in health care. 33(3)
Objectives: The aim of our study was to describe approaches to health technology assessment (HTA) for medicines in the Slovak healthcare system and the related decision-making processes concerning reimbursement for medicines.Methods: Analysis of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efc2f6034340b010c9ece3e467fd9a13
https://pubmed.ncbi.nlm.nih.gov/28434416
https://pubmed.ncbi.nlm.nih.gov/28434416
Autor:
Peter Kukumberg, Jan Luha, Adam Hloska, Gejza Wimmer, Tomas Tesar, Rashmi Shah, Martin Wawruch, Dusan Zatko, Sona Wimmerova, Jan Murin
Publikováno v:
Aging clinical and experimental research. 29(6)
Antiplatelet therapy following a transient ischemic attack (TIA) constitutes an important secondary prevention measure. The study was aimed at evaluating the development of non-persistence with antiplatelet therapy in elderly patients after a TIA and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3000e74b669a5961c47b9e347e58e3a2
https://pubmed.ncbi.nlm.nih.gov/28284002
https://pubmed.ncbi.nlm.nih.gov/28284002
Autor:
Martin, Wawruch, Dusan, Zatko, Gejza, Wimmer, Jan, Luha, Vasil, Hricak, Jan, Murin, Peter, Kukumberg, Tomas, Tesar, Adam, Hloska, Rashmi, Shah
Publikováno v:
Pharmacoepidemiology and drug safety. 26(2)
This study was aimed at evaluating the extent of non-persistence with statin therapy in elderly patients after an ischemic stroke and identifying patient-related characteristics that are risk factors for non-persistence.The evaluable study cohort (n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a854acb45597d8a1f6da7422229f4e06
https://pubmed.ncbi.nlm.nih.gov/27935151
https://pubmed.ncbi.nlm.nih.gov/27935151